Loading...
Back to narrative

CGS: Expanded Buyback Program Will Support Higher Per-Share Earnings Ahead

Medidata Partnership And AI Launch Will Expand Global Reach

CGS logo
CGS
AnalystConsensusTarget
Not Invested
Published 11 Feb 2025

Update shared on 09 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
88.0%
7D
-12.7%

Analysts have modestly raised their price target on Cogstate to approximately $3.30 per share. This reflects slightly higher long term return assumptions and a marginally richer future earnings multiple, while growth and margin forecasts remain largely unchanged.

What's in the News

  • Cogstate Limited has launched a new share repurchase program authorizing the buyback of up to 16,888,479 shares, equal to 10% of its issued share capital, with the program running through November 30, 2026 (company announcement)
  • The Board of Directors formally approved the latest share buyback plan on November 11, 2025, signaling continued focus on capital management and shareholder returns (company announcement)
  • In an update on the prior buyback, Cogstate reported that between July 1, 2025 and November 11, 2025 it repurchased 0 shares under the current tranche, but has cumulatively bought back 5,870,804 shares, or 3.41% of issued capital, for AUD 7.65 million under the program announced October 21, 2024 (company filing)

Valuation Changes

  • Fair value estimate remains unchanged at approximately A$3.30 per share, reflecting stable core valuation assumptions.
  • The discount rate has risen slightly from 7.77% to around 7.79%, implying a marginally higher required return.
  • Revenue growth is effectively unchanged at about 10.19% per year, indicating consistent top-line expectations.
  • Net profit margin is effectively unchanged at roughly 23.21%, suggesting no material revision to long-term profitability assumptions.
  • The future P/E has risen slightly from about 25.9x to 26.6x, pointing to a modestly richer assumed valuation multiple.

Have other thoughts on Cogstate?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.